1. |
Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent st-segment elevation of the European Society of Cardiology (ESC). Eur Heart J, 2016, 37(3): 267-315.
|
2. |
Alame AJ, Karatasakis A, Karacsonyi J, et al. Comparison of the American College of Cardiology/American Heart Association and the European Society of Cardiology guidelines for the management of patients with non-ST-segment elevation acute coronary syndromes. Coron Artery Dis, 2017, 28(4): 294-300.
|
3. |
Worrall-Carter L, McEvedy S, Kuhn L, et al. Systematic review and meta-analyses investigating whether risk stratification explains lower rates of coronary angiography among women with non-ST-segment elevation acute coronary syndrome. J Cardiovasc Nurs, 2017, 32(2): 112-124.
|
4. |
李亚, 耿涛, 刘永兴, 等. NT-proBNP 和 hs-CTNI 联合检测在急性非 ST 段抬高型冠状动脉综合征危险分层及治疗中的意义. 重庆医学, 2013, 42(28): 3377-3378, 3381.
|
5. |
张春艳, 王聪霞, 李永勤, 等. MMP-9 联合 NT-proBNP 在非 ST 段抬高急性冠脉综合征危险分层的研究. 西安交通大学学报: 医学版, 2016, 37(3): 313-317.
|
6. |
Tóth M, Vuorinen KH, Vuolteenaho O, et al. Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol, 1994, 266(4 Pt 2): H1572-H1580.
|
7. |
Struthers AD, Davies J. B-type natriuretic peptide: a simple new test to identify coronary artery disease?. QJM, 2005, 98(10): 765-769.
|
8. |
吴焱贤, 黄裕立, 陈玉映, 等. 血浆 NT-proBNP 与急性非 ST 段抬高型心肌梗死患者冠脉病变的相关性研究. 实用医学杂志, 2013, 29(13): 2135-2137.
|
9. |
陈丰运, 肖骅. NT-proBNP、hs-CRP 和超声心动图与急性冠状动脉综合征病变程度的相关性研究. 重庆医学, 2015, 44(31): 4338-4342.
|
10. |
Schellings DA, Adiyaman A, Dambrink JE, et al. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores. Vasc Health Risk Manag, 2016, 12: 471-476.
|
11. |
Morrow DA, De Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol, 2003, 41(8): 1264-1272.
|
12. |
Jarai R, Huber K, Bogaerts K, et al. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial. Am Heart J, 2010, 159(1): 131-140.
|
13. |
Castro LR, Alencar MC, Barbosa MM, et al. NT-proBNP levels in patients with Non-ST-segment elevation acute coronary syndrome. Arq Bras Cardiol, 2011, 97(6): 454-461.
|
14. |
Riezebos RK, Ronner E, Tijssen JG, et al. NT-ProBNP serum levels reflect severity and extent of ischemia in patients admitted with non-ST-elevation acute coronary syndrome. Acute Card Care, 2006, 8(1): 51-57.
|
15. |
Kashani H, Zeraati H, Mohammad K, et al. Analyzing gensini score as a semi-continuous outcome. J Tehran Heart Cent, 2016, 11(2): 55-61.
|
16. |
熊信林, 唐炯, 蔡琳. 尿酸和白细胞与急性冠状动脉综合征严重程度的相关性研究. 华西医学, 2014, 29(10): 1814-1817.
|
17. |
黄萍, 王斌. 全球急性冠状动脉事件注册评分联合血清肌钙蛋白 Ⅰ 浓度在急性非 ST 段抬高型心肌梗死危险分层中的意义. 华西医学, 2015, 30(12): 2201-2204.
|